Abstract
Several data indicate a connection between Chlamydophila pneumoniae infection and asthma. Although C. pneumoniae is a common cause of infection, not all infected patients develop asthma. This suggests that certain individuals may be genetically predisposed to the chronic effects of C. pneumoniae infection on airway functions. We investigated the possible modifying effect of different polymorphisms on C. pneumoniae infection and on the susceptibility to asthma in 318 children, among those 144 had asthma and 174 had no asthmatic symptoms. C. pneumoniae–specific antibodies were measured by ELISA. Tumor necrosis factor-α (TNFα), monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated on activation normal T cell expressed and secreted) genotypes were determined by PCR–restriction fragment length polymorphism (RFLP). There were no significant differences in the percentage of children positive for C. pneumoniae–specific antibodies between cases and controls. None of the genotypes was associated with altered susceptibility to C. pneumoniae infection. Among asthmatic children carrying the TNFα –308A allele, there were significantly more patients positive for C. pneumoniae–specific IgG, than among control children carrying the same allele (20.1% versus 9.2% of asthmatic versus control children, respectively; p = 0.002; odds ratio = 3.52 (1.52–7.53); p = 0.005). This study indicates the possible roles of polymorphisms in the immune system in the susceptibility to asthma in children infected with C. pneumoniae.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- MCP-1:
-
monocyte chemoattractant protein-1
- RANTES:
-
regulated on activation normal T cell expressed and secreted
References
Ober C, Thompson EE 2005 Rethinking genetic models of asthma: the role of environmental modifiers. Curr Opin Immunol 17: 670–678
Johnston SL, Martin RJ 2005 Chlamydophila pneumoniae and Mycoplasma pneumoniae: A role in asthma pathogenesis?. Am J Respir Crit Care Med 172: 1078–1089
Pasternack R, Huhtala H, Karjalainen J 2005 Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J Allergy Clin Immunol 116: 1123–1128
Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP 1990 A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618–625
Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ 2005 Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60: 1012–1018
Wilson AG, Symons JA, McDowell TL, McDewitt HO, Duff GW 1997 Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195–3199
Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, Lukacs NW 1999 Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2–/– mice: The role of mast cells. J Immunol 163: 2160–2167
Rovin BH, Lu L, Saxena R 1999 A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259: 344–348
Lukacs NW, Strieter RM, Warmington K, Lincoln P, Censue SW, Kunkel SL 1997 Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 158: 4398–4404
Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, Freidhoff LR, Sengler C, Plitt JR, Schleimer RP, Caraballo L, Naidu RP, Levett PN, Beaty TH, Huang SK 2000 Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164: 1612–1616
Rodriguez N, Fend F, Jennen L, Schiemann M, Wantia N, Prazeres da Costa CU, Durr S, Heinzmann U, Wagner H, Miethke T 2005 Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J Immunol 174: 4836–4844
Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, Maass M 2003 Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation 108: 261–265
Gerard HC, Wang Z, Whittum-Hudson JA, El-Gabalawy H, Goldbach-Mansky R, Bardin T, Schumacher HR, Hudson AP 2002 Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 29: 1827–1835
American Thoracic Society 1995 Standardization of spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152: 1107–1136
NHLBI/WHO Workshop Report 1995. Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung, and Blood Institute, Bethesda, MD. Publication No. 95-3659: 144–168.
Szalai C, Kozma GT, Nagy A, Bojszkó Á, Krikovszky D, Szabó T, Falus A 2001 Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108: 375–381
Verkerk MS, Visseren FL, Paul Bouter K, Diepersloot RJ 2003 Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus. Eur J Clin Invest 33: 720–725
Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W, Caldwell HD 1999 Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 162: 3541–3548
Rudmann DG, Moore MW, Tepper JS, Aldrich MC, Pfeiffer JW, Hogenesch H, Tumas DB 2000 Modulation of allergic inflammation in mice deficient in TNF receptors. Am J Physiol Lung Cell Mol Physiol 279: L1047–L1057
Zuany-Amorim C, Manlius C, Dalum I, Jensen MR, Gautam A, Pay G, Mouritsen S, Walker C 2004 Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases. Int Arch Allergy Immunol 133: 154–163
Tavernier J, Pauwels RA 1992 Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 145: 332–336
Thomas PS, Yates DH, Barnes PJ 1995 Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 152: 76–80
Thomas PS, Heywood G 2002 Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 57: 774–778
Randolph AG, Lange C, Silverman EK, Lazarus R, Weiss ST 2005 Extended haplotype in the tumor necrosis factor gene cluster is associated with asthma and asthma-related phenotypes. Am J Respir Crit Care Med 172: 687–692
Louis E, Franchimont D, Piron A, Gavaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J 1998 Tumor necrosis factor gene polymorphism influences TNF-alpha production in lipopolysaccharide-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113: 401–406
Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP 2003 In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33: 469–475
Szalai C, Fust G, Duba J, Kramer J, Romics L, Prohaszka Z, Csaszar A 2002 Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet 39: 46–51
Vatay A, Yang Y, Chung EK, Zhou B, Blanchong CA, Kovacs M, Karadi I, Fust G, Romics L, Varga L, Yu CY, Szalai C 2003 Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Hum Immunol 64: 543–552
Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, Jennings R, Mbena E, Mabey DC 1997 Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 65: 1003–1006
Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C 2003 The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J Allergy Clin Immunol 112: 729–734
Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B, Riva A, Ramoni M, Martinez FD, Weiss ST, Kwiatkowski DJ 2002 Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 190: 9–25
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by OTKA (National Scientific Research Fund, grants T031887, T046372, and TS/2 044707) and a János Bolyai Research Grant.
Rights and permissions
About this article
Cite this article
Tölgyesi, G., Keszei, M., Ungvári, I. et al. Involvement of TNFα –308A Promoter Polymorphism in the Development of Asthma in Children Infected With Chlamydophila pneumoniae. Pediatr Res 60, 543–548 (2006). https://doi.org/10.1203/01.pdr.0000242298.24089.52
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000242298.24089.52
This article is cited by
-
The Regulated upon Activation Normal T-cell Expressed and Secreted (RANTES) −28C/G and −403G/A Polymorphisms and Asthma Risk: A Meta-analysis
Molecular Diagnosis & Therapy (2014)
-
The −308 G/A polymorphism in TNF-α gene is associated with asthma risk: an update by meta-analysis
Journal of Clinical Immunology (2011)
-
Asthma from a pharmacogenomic point of view
British Journal of Pharmacology (2008)
